Related Experiment Video
Updated: Jan 1, 2026
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Cirrhosis: Diagnosis and Management
Andrew Smith1, Katrina Baumgartner1, Christopher Bositis1
1Greater Lawrence Family Health Center, Lawrence, MA, USA.
Cirrhosis, a leading cause of death, is often reversible in early stages. Early detection through screening tests is crucial for managing liver fibrosis and preventing serious complications.
Area of Science:
- Hepatology
- Gastroenterology
- Internal Medicine
Background:
- Cirrhosis is a significant cause of mortality in the US, often asymptomatic until decompensation.
- Early-stage liver fibrosis is increasingly recognized as a reversible condition.
- A large proportion of individuals with cirrhosis remain undiagnosed.
Purpose of the Study:
- To review the current understanding of cirrhosis and liver fibrosis.
- To outline diagnostic workup and screening strategies for cirrhosis.
- To summarize management principles for chronic liver disease and its complications.
Main Methods:
- Review of current research on liver fibrosis and cirrhosis.
- Description of common etiological factors for cirrhosis.
- Summary of diagnostic tests including serological markers, imaging, and noninvasive fibrosis assessments.
- Outline of management strategies for varices, ascites, hepatic encephalopathy, and hepatocellular carcinoma.
Main Results:
- Common causes include viral hepatitis, alcoholic liver disease, and nonalcoholic steatohepatitis.
- Noninvasive tests are effective in identifying patients with minimal or advanced fibrosis.
- Effective management strategies exist for preventing decompensation and mortality.
Conclusions:
- Prompt evaluation is necessary upon detection of clinical signs or abnormal liver tests.
- Comprehensive management, including monitoring and targeted treatments, is key to improving outcomes.
- Regular screening for hepatocellular carcinoma is recommended for patients with cirrhosis.
More Related Videos
04:00Laparoscopic Splenectomy with Pericardial Devascularization for Hypersplenism and Esophageal Variceal Hemorrhage Due to Portal Hypertension
Published on: November 15, 2024
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment:
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow